Ocugen Presents Gene Therapy Platform at Investor and Industry Conferences
Ocugen presented its gene therapy platform at investor and industry conferences.
Related stories
Intel Cites AI Server Demand Behind Q3 2026 Revenue Beat
Intel management cited AI-driven server demand as a driver of its Q3 2026 revenue beat.
M impact | EQUITY | Oct 29, 2026, 10:15 PM UTC
Bunge publishes Q3 2026 earnings call transcript
Bunge published its third-quarter 2026 earnings call transcript.
M impact | EQUITY | Oct 29, 2026, 10:15 PM UTC
Ganzhou Hemay Pharmaceutical: trading in H shares on Hong Kong stock exchange set to begin Nov. 9
L impact | EQUITY | Oct 29, 2026, 10:12 PM UTC
Ganzhou Hemay Pharmaceutical: global offering to include 55.2 million H shares
L impact | EQUITY | Oct 29, 2026, 10:11 PM UTC
Jiangsu Xinde Semiconductor Technology: number of offered shares in global offering 106.6 million H shares
L impact | EQUITY | Oct 29, 2026, 10:10 PM UTC
Suzhou Denglin Technology: dealings in H shares on stock exchange expected to start Nov. 10
L impact | EQUITY | Oct 29, 2026, 10:06 PM UTC